De Nicola, Luca
Cozzolino, Mario http://orcid.org/0000-0002-8494-6252
Genovesi, Simonetta
Gesualdo, Loreto
Grandaliano, Giuseppe
Pontremoli, Roberto
Funding for this research was provided by:
Università degli Studi di Milano
AstraZeneca ITA
Article History
Received: 12 January 2022
Accepted: 18 April 2022
First Online: 18 May 2022
Change Date: 25 August 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: MC has served as a Lecturer for AstraZeneca; LDN has served as a consultant and/or lecturer for Astellas, AstraZeneca, Mundipharma, Novo Nordisk; SG has received speaker fees from Astra Zeneca, Boehringer-Ingelheim; LG has provided research support for Abionyx, Sanofi, has served as a speaker for Fresenius, Estor, Werfen, Astellas, AstraZeneca, Travere and as a consultant for Sandoz, Sanofi, Baxter, Mundipharma, Estor, Pharmadoc, Retrophin, Travere, AstraZeneca, GSK, Novartis, Chinook; GG has no conflict of interests; RP has received speaker fees from Astra Zeneca, Boehringer-Ingelheim, Menarini, Eli-Lilly, MSD, Novo Nordisk, Alfasigma.
: Ethical statement is no needed.